Saudi Arabia Diabetes Devices Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Saudi Arabia is among the countries with the highest diabetes prevalence in the world, which has created sustained demand for diagnostic and therapeutic diabetes devices. The market is currently estimated at approximately USD 0.93 billion in 2025 and is growing at a compound annual rate of about 21.8%, outpacing many other medical device categories in the region. Healthcare expenditure linked to diabetes in the Kingdom has been reported in the multi-billion-dollar range, underscoring the scale of the public health challenge.

• •Market size in 2025: approximately USD 0.93 billion
• •Forecast CAGR: roughly 21.8% per year
• •Diabetes-related healthcare spending in Saudi Arabia reached about USD 7.3 billion in 2024

Rising obesity, sedentary lifestyles, and an aging population are pushing diabetes prevalence higher, increasing the installed base of patients who require monitoring and insulin delivery devices. Vision 2030 healthcare reforms are expanding insurance coverage, home healthcare, and digital health infrastructure, all of which support device adoption. Strong consumer interest in fitness trackers and mobile health applications is also accelerating broader wearable health technology penetration in the Kingdom.

• •Vision 2030 is expanding home healthcare and digital health capacity
• •The local wearable technology market reached roughly USD 626 million in 2023
• •Prediabetes and obesity intervention programs are creating early-stage device demand

The market is typically segmented by device type into blood glucose monitoring systems, CGMs, insulin pumps, insulin pens, and wearable or connected digital health devices. Monitoring devices, particularly CGMs, represent the fastest-growing segment due to consumer preference for real-time data and integration with smartphones. Within the Middle East and Africa region, Saudi Arabia and the United Arab Emirates account for the largest share of advanced diabetes device revenue, supported by higher per-capita healthcare spending.

• •CGMs and connected wearables are the fastest-growing device category
• •Saudi Arabia leads the Gulf in adoption of advanced diabetes technology
• •Home-based and remote monitoring solutions are gaining share over hospital-only use

What are the recent trends and outlook?

The market outlook is supported by the convergence of wearable AI, mobile health applications, and therapeutic device design, with analysts projecting double-digit growth for therapeutic wearables through the end of the decade. Integration of CGMs with smartphone apps, telehealth platforms, and AI-driven decision support is becoming a standard expectation rather than a premium feature. With Vision 2030 funding, regulatory modernization, and high consumer digital readiness, Saudi Arabia is positioned to remain the largest and fastest-growing diabetes devices market in the Middle East and Africa region.

• •Therapeutic wearables are projected to grow at more than 25% CAGR through 2030
• •AI-enabled personalization and predictive alerts are emerging as key differentiators
• •Regulatory and reimbursement reforms under Vision 2030 are expected to sustain double-digit market growth